Income Taxes - Additional Information (Detail) (USD $)
|
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
Income Tax [Line Items] | |||
Foreign taxes on undistributed earnings of foreign subsidiaries | $ 8,000,000us-gaap_UndistributedEarningsOfForeignSubsidiaries | ||
Foreign tax credit | 1,400,000us-gaap_TaxCreditCarryforwardAmount | ||
State and foreign tax credit carryforwards expiration beginning year | 2015 | ||
State and foreign tax credit carryforwards expiration ending year | 2029 | ||
Operating loss carryforwards, expiration dates | These state net operating loss carryforwards amount to approximately $23.3 million and expire at various dates from 2028 through 2034. | ||
Operating loss carryforwards expiration beginning year | 2028 | ||
Operating loss carryforwards expiration ending year | 2034 | ||
Tax benefits related to stock option exercises | 5,300,000us-gaap_DeferredTaxExpenseFromStockOptionsExercised | 1,200,000us-gaap_DeferredTaxExpenseFromStockOptionsExercised | |
Penalties or interest liabilities accrued | 0us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued | 0us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued | |
Penalties or interest expense | 0us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense | 0us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense | 0us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense |
Pretax income | 4,300,000atro_PretaxIncomeFromForeignSubsidiary | 200,000atro_PretaxIncomeFromForeignSubsidiary | 1,000,000atro_PretaxIncomeFromForeignSubsidiary |
Estimated Benefits for research and development tax credits | 0us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment | ||
Tax benefits | 700,000atro_TaxBenefitsThatWouldHaveRecognizedHadNewLawBeenEnacted | ||
Tax benefits Reserve | 700,000atro_DeferredTaxAssetValuationAllowanceThatWouldHaveRecognizedHadNewLawBeenEnacted | ||
Amount recognized in tax credit | 1,100,000us-gaap_IncomeTaxReconciliationTaxCreditsResearch | ||
State and Local Jurisdiction [Member] | |||
Income Tax [Line Items] | |||
Net operating loss carryforwards |
$ 23,300,000us-gaap_OperatingLossCarryforwards / us-gaap_IncomeTaxAuthorityAxis = us-gaap_StateAndLocalJurisdictionMember |
X | ||||||||||
- Definition
Deferred tax asset valuation allowance that would have recognized had new law been enacted. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Operating loss carryforwards expiration beginning year. No definition available.
|
X | ||||||||||
- Definition
Operating loss carry forwards expiration dates description. No definition available.
|
X | ||||||||||
- Definition
Operating loss carry forwards expiration ending year. No definition available.
|
X | ||||||||||
- Definition
Pretax income from foreign subsidiary. No definition available.
|
X | ||||||||||
- Definition
Tax benefits that would have recognized had new law been enacted. No definition available.
|
X | ||||||||||
- Definition
Tax credit carryforward expiration year range end. No definition available.
|
X | ||||||||||
- Definition
Tax credit carryforward expiration year range start. No definition available.
|
X | ||||||||||
- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|